--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "MyRxProfile: Pill & Drug Guide" developer_entity: "MyRxProfile LLC" bundle_id: "thriftway.MyRxProfile" app_store_id: "1117472512" category: "Medical" primary_platform: "ios" primary_monetization: "Subscription" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2026-08-13" report_date: "2026-08-17" last_verified: "2026-08-17T00:00:00.000Z" report_version: "4.5.50" total_reviews: 34 overall_rating: 3.4 sentiment: "Frustrated" sentiment_score: 25 confidence: "medium" confidence_score: 0.6 top_praise_theme: "Detailed drug information and interaction warnings provide value for users managing multiple complex medication regimens" top_complaint_theme: "Critical drug interaction checks fail to flag dangerous combinations, creating significant safety risks for users" review_sample_size: 14 total_review_count: 14 analyzed_review_count: 14 data_age_days: 7 momentum_velocity: "maintenance" intelligence_version: 3 tags: ["medical", "subscription", "frustrated sentiment", "mobile app", "app review", "app analysis", "individuals", "families", "managing"] canonical_url: "https://marlvel.ai/apps/myrxprofile-pill-drug-guide" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # MyRxProfile: Pill & Drug Guide Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Subscription - **Signal**: Rating 3.35 · Sentiment Frustrated - **Recent focus**: Critical drug interaction checks fail to flag dangerous combinations, creating significant safety risks for users (top complaint) · Detailed drug information and interaction warnings provide value for users managing multiple complex medication regimens (top praise) > **TL;DR:** MyRxProfile: Pill & Drug Guide is a medical app by MyRxProfile LLC, rated 3.35/5 by 34 users, with Frustrated user sentiment (25/100), available on iOS. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** MyRxProfile: Pill & Drug Guide faces Frustrated user sentiment (3.35/5 from 34 reviews), with users reporting critical drug interaction checks fail to flag dangerous combinations, creating significant safety risks for users as the primary concern. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 3.35/5 (34 reviews) | | **User Mood** | Frustrated | | **Category** | Medical | | **Developer** | MyRxProfile LLC | | **Pricing** | Subscription | | **Platforms** | iOS | | **Confidence** | Medium (0.6/1.0) | | **Data Age** | 7d | ## Metadata & Market Performance - **Publisher:** MyRxProfile LLC - **Category:** Medical - **Target Audience:** Individuals and families managing complex, multi-medication regimens who require centralized safety monitoring. - **Platforms:** iOS - **Version Reviewed:** 4.5.50 - **Report Date:** 2026-08-17 - **Signal Count:** 14 reviews analyzed - **Confidence:** Medium (0.6/1.0) - **App Store ID (iOS):** 1117472512 - **Bundle ID:** thriftway.MyRxProfile - **Performance Trend:** Stable - **Data Window:** Analysis based on signals collected up to 2026-08-17 ## Executive Snapshot **What it is:** MyRxProfile is a medication management and interaction-tracking app for families on iOS. **Why users hire it:** It removes the cognitive load of tracking complex medication schedules across multiple family members, though its current reliability issues limit its utility as a safety tool. ## App DNA (Features & Intent) - **[Differentiator] Adverse Drug Interaction Detection:** Identifies potential clashes between medications and supplements. - **[Differentiator] Family Profiles:** Supports multiple personalized medication spaces within a single account. * *User Intent:* Users value self-expression and personalized experiences. - **[Standard] Medicine Scanner:** Uses device camera to scan barcodes for medication identification. ## Market Position {#market-position} MyRxProfile holds a 3.35-star rating across 34 total ratings. The subscription-only model, combined with a maintenance-only update cadence, leaves the app vulnerable to competitors that offer free, reliable interaction checks. ## Monetization Strategy - **Model:** Subscription - **Tiers:** Paid subscription required for full feature access, Free trial available - **Analysis:** The subscription-only model gates all core functionality, including safety alerts, creating a high conversion risk when the interaction engine fails to perform. ## 🔴 User Sentiment (Medium Confidence: 14 of 14 reviews analyzed) {#user-sentiment} - **Overall Rating:** 3.35/5 - **Platform Split:** iOS 3.4/5 (34 ratings) - **Overall Sentiment:** Frustrated ### Top Praises - **Detailed drug information and interaction warnings provide value for users managing multiple complex medication regimens** - **The user interface is described as visually appealing and easy to navigate for new users** ### Top Complaints (Impact Areas) - **Critical drug interaction checks fail to flag dangerous combinations, creating significant safety risks for users** ## SWOT Analysis {#swot} **Core Strengths:** - Family-specific medication spaces allow for centralized safety monitoring across households **Growth Levers:** - Manual entry feature for missing medications would address the top user frustration regarding the limited database ## Recent Changes (v2 → v3) {#recent-changes} The app remains in a maintenance-only state with no functional changes or feature releases. The primary shift is a more critical framing of the subscription-only model as a liability against free, reliable market alternatives. **Overall trend**: Stable **Compared at**: 2026-08-17 ### Medium-impact changes - **[Shifted] Competitive Stance** (positioning) - **[Shifted] SWOT Re-categorization** (swot) ## What's New - **Latest (v4.5.50, 3 days ago):** Routine maintenance focused on bug fixes and stability improvements. ## App Momentum (Maintenance) {#momentum} - Ships bug fixes only. - Last major release over six months ago. > **Cadence:** 2 total versions · 0 majors in last 6 months · 3 days since last update · 56 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} MyRxProfile: Pill & Drug Guide is a medical app. With a 3.35/5 rating from 34 reviews, it faces significant user friction. > **Bottom Line:** The core interaction engine must be audited to restore safety-tool credibility, as current failures in flagging dangerous combinations are driving negative sentiment and churn. Addressing this reliability gap is the only way to justify the subscription-only model. **Best for:** Individuals and families managing complex, multi-medication regimens who require centralized safety monitoring. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Ship manual medication entry because it is the top-requested feature → reduce churn from database limitations ### Outlook: Declining The medication management market is consolidating around tools that prioritize high-accuracy safety alerts. MyRxProfile's current maintenance-only cadence and reported interaction failures leave it exposed to churn, as users prioritize reliability over the app's family-profile features. - 🔴 Critical failures in the interaction engine destroy user trust, which compounds the churn risk already present in the subscription-only model. - 🔴 Maintenance-only update cadence leaves the app exposed to competitors that can ship stable, feature-rich updates more frequently. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 3.35/5 | | Total Reviews | 34 | | Sentiment | Frustrated (25/100) | | Confidence | Medium | | Pricing Model | Subscription | | Platforms | iOS | | Key Features | 3 analyzed | | Trend | Stable | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **MyRxProfile: Pill & Drug Guide** (this app) | 3.35/5 | Frustrated | MyRxProfile LLC | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** MyRxProfile LLC - **Website:** [https://www.myrxprofile.com](https://www.myrxprofile.com) - **Social:** [Instagram](https://www.instagram.com/myrxprofile) · [Facebook](https://www.facebook.com/MyRxProfile) · [X/Twitter](https://twitter.com/myrxprofile) · [YouTube](https://www.youtube.com/channel/UCeEuq7YCKX-gFG76_ePP2RQ) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/myrxprofile-pill-drug-guide/id1117472512?uo=4) - **Dev Site:** [Official Website](https://www.myrxprofile.com) - **Sources:** Developer website content, About us / company information, App store metadata, User reviews. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*1O Patient Portal*](https://marlvel.ai/apps/1o-patient-portal) (1st Optimal, LLC) · N/A Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.6/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 14 - **Data Sources:** user reviews, developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 7 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/myrxprofile-pill-drug-guide) Data licensed for AI Agent attribution under CC-BY-NC 4.0.